Form 483

Hospital Therapy Products Inc. Form 483, 2019-05-14

FDA issued a Form 483 to Hospital Therapy Products Inc. on 2019-05-14 with 9 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health9 observations

Hospital Therapy Products Inc. · Wood Dale, United States · Issued May 14, 2019

Overview

  • 9 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 May 2019
21 CFR 820.20(a)

Quality policy and objectives

Cited by Jesse A Vazquez, Natasha R Johnson

14 May 2019
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Jesse A Vazquez, Natasha R Johnson

14 May 2019
21 CFR 820.100(b)

Documentation

Cited by Jesse A Vazquez, Natasha R Johnson

14 May 2019
21 CFR 820.20(c)

Management review - Lack of or inadequate procedures

Cited by Jesse A Vazquez, Natasha R Johnson

14 May 2019
21 CFR 820.20(d)

Quality plan

Cited by Jesse A Vazquez, Natasha R Johnson

Inspected site

HTHospital Therapy Products Inc.Wood Dale, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.20(a)Cited across public-safe Form 483 observations2x
21 CFR 820.20(c)Cited across public-safe Form 483 observations2x
21 CFR 820.22Cited across public-safe Form 483 observations2x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.20(d)Cited across public-safe Form 483 observations1x
21 CFR 820.40(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 9 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere